ask="60.00"
ask_size="100"
average_daily_volume="367832"
bid="N/A"
bid_size="N/A"
book_value="0.00"
change="+1.96"
change_from_200_day_moving_average="-1.40"
change_from_50_day_moving_average="1.95"
change_from_52_week_high="-12.45"
change_From_52_week_low="18.18"
change_in_percent="+4.21%"
close="48.53"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-2.44"
ebitda="-97.57M"
eps_estimate_current_year="-3.81"
eps_estimate_next_quarter="-1.13"
eps_estimate_next_year="-1.58"
ex_dividend_date="N/A"
float_shares="24414000"
high="48.68"
high_52_weeks="60.98"
last_trade_date="2/27/2017"
last_trade_price="48.53"
last_trade_size="26522"
last_trade_time="4:00pm"
low="45.51"
low_52_weeks="30.35"
market_capitalization="1.33B"
moving_average_200_day="49.93"
moving_average_50_day="46.58"
name="Five Prime Therapeutics
Inc."
notes="N/A"
one_year_target_price="60.50"
open="46.26"
pe_ratio="N/A"
peg_ratio="0.20"
percent_change_from_200_day_moving_average="-2.81%"
percent_change_from_50_day_moving_average="+4.18%"
percent_change_from_52_week_high="-20.42%"
percent_change_from_52_week_low="+59.90%"
previous_close="46.57"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="N/A"
price_per_sales="41.63"
revenue="30.69M"
shares_outstanding="27436000"
short_ratio="6.80"
stock_exchange="NMS"
symbol="FPRX"
volume="503687"
weeks_range_52="30.35 - 60.98"
